A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2006
11/15/2006	EP1427718B1 Benzothiepine ileal bile acid transport inhibotors
11/15/2006	EP1414443B1 BENZIMIDAZO 4,5-f\|ISOQUINOLINONE DERIVATIVES
11/15/2006	EP1406899B1 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/15/2006	EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006	EP1152731B1 A skin care composition that mediates cell to cell communication
11/15/2006	EP0969836B1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/15/2006	CN1864434A Wireless microphone communication system
11/15/2006	CN1863907A Method of preparing hair papilla cell preparation, composition and method for regenerating hair follicle and animal having regenerated hair follicle
11/15/2006	CN1863811A Stable vitamin B6 derivative
11/15/2006	CN1863800A Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions
11/15/2006	CN1863784A 2-naphthylimino-1,3-thiazine derivative
11/15/2006	CN1863548A Methods and compositions for treating disorders of the extracellular matrix
11/15/2006	CN1863529A Topical compositions comprising telmesteine for treating dermatological disorders
11/15/2006	CN1863526A Collagen productin enhancer and production process and use thereof
11/15/2006	CN1863521A Method for decreasing sebum production
11/15/2006	CN1863503A Hair growth stimulant composition
11/15/2006	CN1861184A Application of composition for preparing medicine to treat chilblain disease
11/15/2006	CN1861170A Hair-growth medicated liquid and its prepn. method
11/15/2006	CN1861169A Skin care medicated liquid for eliminating acne
11/15/2006	CN1861092A Application of chlorine-contg. disinfectant in pharmaceutics
11/15/2006	CN1861065A Formula and prepn. method for compound ointment contg. zinc undecenate
11/15/2006	CN1861059A Hydrophilic gel type percutaneous plaster contg. capsaicin, and its prepn. method
11/15/2006	CN1861042A Weiding ointment and its prepn. process
11/15/2006	CN1284851C Somatic cell derived embryonic stem cell and its differentiated cell
11/15/2006	CN1284793C C-aryl glucoside sglt2 inhibitors
11/15/2006	CN1284772C Benzamide kind histon deacetylase inhibiting agent having dissociation and antibred activity and its medicinal preparation
11/15/2006	CN1284600C Biological fluid film of recombined human keratinized cell growth factor-2 and its preparing process
11/15/2006	CN1284591C Safflower oil
11/15/2006	CN1284582C Bactoria oral liquid for nourishing face and removing freckles
11/15/2006	CN1284566C Compound powder for soft mask for dispeling pocks
11/15/2006	CN1284560C Multifunctional external-applied ointment and production thereof
11/15/2006	CN1284554C Medicine for treating acute urticaria
11/15/2006	CN1284552C Oral Chinese traditional medicine preparation for dispelling acne
11/15/2006	CN1284538C Cream for treating keratosis and chap
11/15/2006	CN1284522C Dextrose and insulin fluid formulation for intravenous infusion
11/14/2006	US7135600 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis
11/14/2006	US7135587 Such as 3-biphenyl-4-yl-3-(2-(3-(pyridin-2-ylamino)pro-poxycarbonylamino) -ethanoylamino)propionic acid; thromboses, cardiac infarction, coronary heart disease, arteriosclerosis, inflammation, tumors. osteoporosis, infections, restenosis
11/14/2006	US7135568 Substituted pyrazolopyrimidines and thiazolopyrimidines
11/14/2006	US7135494 Antitumoral carbazoles
11/14/2006	US7135491 5-Aryltetrazole compounds and uses thereof
11/14/2006	US7135471 Aryl oximes
11/14/2006	US7135464 Method of administering decitabine
11/14/2006	US7135454 Use of SLURP-1 compositions for treating schizophrenia
11/14/2006	US7135195 Colorless antimicrobioal aqueous suspension of colloidal silver particles having an interior of elemental silver and a surface of silver oxide of given particle diameters; antiseptic and surface disinfectant and for treatment of viral, fungal, and bacterial infections
11/14/2006	CA2408191C Biocidal polymers based on guanidine salts
11/14/2006	CA2362233C Process for cross-linking hyaluronic acid to polymers
11/14/2006	CA2342271C Gem substituted hydroxamic acids
11/14/2006	CA2314623C Use of at least one hydroxystilbene as an anti-glycation agent
11/14/2006	CA2308873C Use of at least one inhibitor of at least one calcium channel in wrinkle treatment
11/14/2006	CA2263846C Novel pyranoside derivatives
11/14/2006	CA2040410C Wound healing compositions containing il-1 and a growth factor
11/09/2006	WO2006118328A1 Degranulation inhibitor
11/09/2006	WO2006118299A1 Gpcr inhibitor
11/09/2006	WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006	WO2006118131A1 Peptide having anti-anxiety effect and method for screening thereof
11/09/2006	WO2006118079A1 Antiaging agnet for skin
11/09/2006	WO2006117995A1 Therapeutic agent for loss of scalp hair
11/09/2006	WO2006117885A1 External preparation for skin
11/09/2006	WO2006117573A1 Combination therapy
11/09/2006	WO2006117405A1 The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy
11/09/2006	WO2006117076A1 Use of indolin-phenylsulfonamide derivatives
11/09/2006	WO2006117075A1 Use of indolin-phenylsulfonamide derivatives
11/09/2006	WO2006117019A1 Preparation and procedure for the treatment of udders
11/09/2006	WO2006116804A1 Processed hyoscyamus seed agent for the treatment of tissue disruption
11/09/2006	WO2006097337A9 11β-HYDROXYSTEROID DEHYDROGENASES
11/09/2006	WO2006083947A3 Compositions and methods for treating fibrotic disorders
11/09/2006	WO2006048242A3 Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
11/09/2006	US20060252943 Chemical process
11/09/2006	US20060252839 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
11/09/2006	US20060252838 Use of spermine and/or spermidine against skin ageting in dietary, pharmaceuetical or cosmetic compositions
11/09/2006	US20060252810 e.g. 5-(4-Fluorophenyl)-4-(4-pyridinyl)imidazole-2-thio-3-propyl-N-phthalimide; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
11/09/2006	US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006	US20060252792 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
11/09/2006	US20060252730 Adenosine receptor antagonists and methods of making and using the same
11/09/2006	US20060252695 Analysis and separation of platelet-derived growth factor proteins
11/09/2006	US20060252679 Preventive and/or trerapeutic drgs for itch
11/09/2006	US20060252036 Alteration of rab38 function to modulate mammalian pigmentation
11/09/2006	US20060251708 Coenzyme q10 containing proliposome and preparation thereof
11/09/2006	US20060251653 Methods for treating interleukin-6 related diseases
11/09/2006	US20060251651 Antagonist and agonist which bind to a strong binding site of chemokine receptor
11/09/2006	US20060251604 Method for diagnosing alopecia
11/09/2006	CA2606734A1 Method of using oxidative reductive potential water solution in dental applications
11/09/2006	CA2606162A1 Peptide having antianxiety activity and screening method therefor
11/08/2006	EP1719780A2 Mammalian cytokine-like polypeptide-10
11/08/2006	EP1719779A2 Antibodies against Matin
11/08/2006	EP1719757A1 Bicyclo derivative
11/08/2006	EP1719522A1 Medicinal composition comprising TCF-II
11/08/2006	EP1719511A2 N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide, a pharmaceutical composition comprising the same and use thereof
11/08/2006	EP1719509A1 Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiodependent diseases such as cancer and psoriasis
11/08/2006	EP1718635A1 Piperidinyl targeting compounds that selectively bind integrins
11/08/2006	EP1718333A2 Methods of modulating cd200 and cd200r
11/08/2006	EP1718318A2 Wound healing composition
11/08/2006	EP1718317A1 Wound healing profile
11/08/2006	EP1718296A2 Use of metronidazole for preparing a pharmaceutical composition for treating pathologies related to the b-type receptor of interleukin 8 and/or to a pacap type 1 receptor
11/08/2006	EP1718295A2 Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous inflammation
11/08/2006	EP1718290A1 Composition, comprising l-serine, l-isoleucine, folic acid and trace elements, for treating psoriasis
11/08/2006	EP1718285A2 Use of a compound modulating at least one receiver selected in a group comprising an interleukin 8 type b receptor and pacap-1 receptor for preparing a pharmaceutical composition for rosacea treatment
11/08/2006	EP1294691B1 Serine protease inhibitors
11/08/2006	EP1227791B1 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition
11/08/2006	EP1021190B1 Amid derivatives as growth hormone release promotors

1 ... 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 ... 1065